|
 |
|
Archive |
 |
| 11 July 2005, Volume 93, Number 1 |
 |
 |
| Review | back to top |  |
Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers
P Mehlen & F Llambi |
Abstract | Full Article | PDF
|
1 |  |
| Clinical Studies | back to top |  |
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
L Del Mastro, P Bruzzi, G Nicolò, G Cavazzini, A Contu, M D'Amico, A Lavarello, F Testore, B Castagneto, E Aitini, L Perdelli, C Bighin, R Rosso, Marco Venturini & other participants |
Abstract | Full Article | PDF
|
7 |
Soybean products and reduction of breast cancer risk: a case-control study in Japan
K Hirose, N Imaeda, Y Tokudome, C Goto, K Wakai, K Matsuo, H Ito, T Toyama, H Iwata, S Tokudome & K Tajima |
Abstract | Full Article | PDF
|
15 |
Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients
S-T Lim, E-H Wong, K-L Chuah, S-S Leong, W-T Lim, M-H Tay, C-K Toh & E-H Tan |
Abstract | Full Article | PDF
|
23 |
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
F Cappuzzo, S Novello, F De Marinis, V Franciosi, M Maur, A Ceribelli, V Lorusso, F Barbieri, L Castaldini, E Crucitta, L Marini, S Bartolini, G V Scagliotti & L Crinò |
Abstract | Full Article | PDF
|
29 |
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
C Bengala, V Guarneri, E Giovannetti, M Lencioni, E Fontana, V Mey, A Fontana, U Boggi, M Del Chiaro, R Danesi, S Ricci, F Mosca, M Del Tacca & P F Conte |
Abstract | Full Article | PDF
|
35 |
A randomised controlled trial of nurse-managed trial conclusion following early phase cancer trial participation
K Cox, E Wilson, A Arthur, R Elkan & S Armstrong |
Abstract | Full Article | PDF
|
41 |
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar
P M Fracasso, K A Blum, M K Ma, B R Tan, L P Wright, S A Goodner, C L Fears, W Hou, M A Arquette, J Picus, A Denes, J E Mortimer, L Ratner, S P Ivy & H L McLeod |
Abstract | Full Article | PDF
|
46 |
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours
R T Penson, M V Seiden, U A Matulonis, L J Appleman, A F Fuller Jr, A Goodman, S M Campos, J W Clark, M Roche & J P Eder Jr |
Abstract | Full Article | PDF
|
54 |
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer
N C Levitt, D J Propper, S Madhusudan, J P Braybrooke, C Echeta, R te Poele, S L Davies, E Flanagan, I D Hickson, S Joel & T S Ganesan |
Abstract | Full Article | PDF
|
60 |  |
| Translational Therapeutics | back to top |  |
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells
M Amit-Vazina, S Shishodia, D Harris, Q Van, M Wang, D Weber, R Alexanian, M Talpaz, B B Aggarwal & Z Estrov |
Abstract | Full Article | PDF
|
70 |
Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (CaelyxÔ) in human osteosarcoma xenografts
L Eikenes, M Tari, I Tufto, Ø S Bruland & C de Lange Davies |
Abstract | Full Article | PDF
|
81 |
The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines
D Kostrzewa-Nowak, M J I Paine, C R Wolf & J Tarasiuk |
Abstract | Full Article | PDF
|
89 |
The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification
M Cemazar, I Wilson, V E Prise, K M Bell, S A Hill & G M Tozer |
Abstract | Full Article | PDF
|
98 |
Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer
L Gibault, J-P Metges, V Conan-Charlet, P Lozac'h, M Robaszkiewicz, C Bessaguet, N Lagarde & A Volant |
Abstract | Full Article | PDF
|
107 |  |
| Molecular Diagnostics | back to top |  |
Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability
T Maeda, H Tashiro, H Katabuchi, M Begum, H Ohtake, T Kiyono & H Okamura |
Abstract | Full Article | PDF
|
116 |
Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas
L M Bäcklund, B R Nilsson, L Liu, K Ichimura & V P Collins |
Abstract | Full Article | PDF
|
124 |
Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma
A Toma, E Otsuji, Y Kuriu, K Okamoto, D Ichikawa, A Hagiwara, H Ito, T Nishimura & H Yamagishi |
Abstract | Full Article | PDF
|
131 |
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
G-B Qiao, Y-L Wu, X-N Yang, W-Z Zhong, D Xie, X-Y Guan, D Fischer, H-C Kolberg, S Kruger & H-W Stuerzbecher |
Abstract | Full Article | PDF
|
137 |
Expression of pendrin in benign and malignant human thyroid tissues
J Skubis-Zegad o, A Nikodemska, E Przytu a, M Mikula, K Bardadin, J Ostrowski, B E Wenzel & B Czarnocka |
Abstract | Full Article | PDF
|
144 |
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete
A Yannopoulos, E Dimitriadis, A Scorilas, T Trangas, E Markakis & M Talieri |
Abstract | Full Article | PDF
|
152 |  |
| Epidemiology | back to top |  |
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma
P Brennan, G Scélo, K Hemminki, L Mellemkjaer, E Tracey, A Andersen, D H Brewster, E Pukkala, M L McBride, E V Kliewer, J M Tonita, A Seow, V Pompe-Kirn, C Martos, J G Jonasson, D Colin & P Boffetta |
Abstract | Full Article | PDF
|
159 |
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype
S E Bojesen, A Tybjærg-Hansen, C K Axelsson & B G Nordestgaard |
Abstract | Full Article | PDF
|
167 |
|
 |
|